Zhou W - Search Results

1

Reshaping cell line development and CMC strategy for fast responses to pandemic outbreak.

Zhang Z, Chen J, Wang J, Gao Q, Ma Z, Xu S, Zhang L, Cai J, Zhou W. Zhang Z, et al. Among authors: zhou w. Biotechnol Prog. 2021 Sep;37(5):e3186. doi: 10.1002/btpr.3186. Epub 2021 Jul 19. Biotechnol Prog. 2021. PMID: 34148295

2

Rapidly accelerated development of neutralizing COVID-19 antibodies by reducing cell line and CMC development timelines.

Tan KW, Ji P, Qian Z, Gao Q, Wang S, Li Q, Gu M, Zhang Q, Hou C, Huang Y, Lian D, Wang J, Zhang Z, Zhang S, Wu J, Zhou W. Tan KW, et al. Among authors: zhou w. Biotechnol Bioeng. 2022 Dec 8:10.1002/bit.28302. doi: 10.1002/bit.28302. Online ahead of print. Biotechnol Bioeng. 2022. PMID: 36482495 Free PMC article.

3

Modulating and optimizing Pluronic F-68 concentrations and feeding for intensified perfusion Chinese hamster ovary cell cultures.

Wei Z, Xia Y, Su Y, Quan Y, Sun L, Wang S, Zhu F, Chen Z, Tian J, Wang WC, Zhou W, Yu H. Wei Z, et al. Among authors: zhou w. Biotechnol Prog. 2023 Jul-Aug;39(4):e3340. doi: 10.1002/btpr.3340. Epub 2023 Mar 27. Biotechnol Prog. 2023. PMID: 36970759

4

Further accelerating biologics development from DNA to IND: the journey from COVID-19 to non-COVID-19 programs.

Tan KW, Ji P, Zhou H, Zhang S, Zhou W. Tan KW, et al. Among authors: zhou h, zhou w. Antib Ther. 2024 Jan 24;7(1):96-104. doi: 10.1093/abt/tbae001. eCollection 2024 Jan. Antib Ther. 2024. PMID: 38371952 Free PMC article. Review.

5

Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture.

Qin Y, Ma R, Li Y, Li Y, Chen G, Zhou W. Qin Y, et al. Among authors: zhou w. Antib Ther. 2022 May 3;5(2):111-120. doi: 10.1093/abt/tbac009. eCollection 2022 Apr. Antib Ther. 2022. PMID: 35719210 Free PMC article.

6

Correlation between the Protein Pharmaceutical Surface Activity and Interfacial Stability.

Wang Y, Wang T, Chen Q, Zhou W, Guo J. Wang Y, et al. Among authors: zhou w. Mol Pharm. 2023 May 1;20(5):2536-2544. doi: 10.1021/acs.molpharmaceut.2c01114. Epub 2023 Apr 10. Mol Pharm. 2023. PMID: 37036270

7

Advancing injection force modeling and viscosity-dependent injectability evaluation for prefilled syringes.

Wu L, Li H, Wang Y, Liu C, Zhao Z, Zhuang G, Chen Q, Zhou W, Guo J. Wu L, et al. Among authors: zhou w. Eur J Pharm Biopharm. 2024 Apr;197:114221. doi: 10.1016/j.ejpb.2024.114221. Epub 2024 Feb 18. Eur J Pharm Biopharm. 2024. PMID: 38378097

8

A Review of Recent FDA-Approved Biologic-Device Combination Products.

Guo J, Weng J, Zhu Q, Zhou F, Chen Q, Gu X, Zhou W. Guo J, et al. Among authors: zhou f, zhou w. J Pharm Sci. 2024 Apr;113(4):866-879. doi: 10.1016/j.xphs.2023.12.022. Epub 2023 Dec 29. J Pharm Sci. 2024. PMID: 38160713 Review.

9

Knowledge, Attitudes and Willingness of Caregivers of Preterm Infants Toward Autism: A Cross-Sectional Study.

Ma D, Luo H, Wang Y, Zhou W, Lu Y, Lv B, Zhang L, Hua Y. Ma D, et al. Among authors: zhou w. Int J Dev Neurosci. 2025 Feb;85(1):e10411. doi: 10.1002/jdn.10411. Int J Dev Neurosci. 2025. PMID: 39760439

10

The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review.

Mori T, Nagaraj NR, Surico PL, Zhou W, Parmar UPS, D'Esposito F, Gagliano C, Musa M, Zeppieri M. Mori T, et al. Among authors: zhou w. Open Life Sci. 2024 Dec 31;19(1):20221023. doi: 10.1515/biol-2022-1023. eCollection 2024. Open Life Sci. 2024. PMID: 39759107 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,976 results

Search Page

Filters